FDA
- Marketing authorisation holder: ROCHE
- Status: approved
Noctan (METHYPRYLON) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
ROCHE holds the US marketing authorisation.